Rebecca Ross

Special Counsel
Full contact info

Experience

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Mandy Ching
Associate, London
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Associate, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

Zenas BioPharma Announces $225 Million IPO

September 16, 2024

Cooley advised Morgan Stanley, Jefferies, Citigroup and Guggenheim Securities as the underwriters of Zenas BioPharma’s $225 million initial public offering.

Read more

Related contacts

Richard Segal
Partner, New York
Denny Won
Partner, San Francisco
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
David Peinsipp
Partner, San Francisco
Madhuri Roy
Partner, Palo Alto
Geoffrey Spolyar
Partner, Boston
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Nathaniel Hearn Jr.
Associate, Chicago
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Aaron Level
Associate, New York
Brenna McGuire
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Jesse Schulman
Associate, Colorado
Nitasha Bennett
Patent Agent, San Diego
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Grafana Labs Completes $270 Million Primary and Secondary Transaction

August 21, 2024

Cooley advised Grafana Labs, the company behind ubiquitous, open and composable operational dashboards, on the successful completion of its approximately $270 million primary and secondary transaction.

Read more

Related contacts

Kevin Rooney
Partner, San Francisco
Rachel M. Burns
Special Counsel, San Francisco
Rachel Lydon
Associate, San Diego
Alanna Anderson
Associate, Palo Alto
Melanie Yuvienco
Paralegal Specialist, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
John Sellers
Partner, Palo Alto
Karen Tsai
Special Counsel, Washington, DC
Jane Jun
Associate, Palo Alto
Natalie D. Vernon
Associate, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

2024 08 13 Encord Announces 30 Million Series B

August 13, 2024

Cooley advised Encord, a data development platform for multimodal artificial intelligence, on its $30 million Series B financing.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Lindsy Solanki
Special Counsel, Palo Alto
Meg Begur
Associate, Washington, DC
Joseph A. Kroon
Associate, Palo Alto
Christopher Kimball
Partner, Washington, DC
Jonathan Rivinus
Partner, Colorado
John Sellers
Partner, Palo Alto
Nicola Squire
Partner, London
Christine Graham
Special Counsel, London
Rebecca Ross
Special Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Shelby Saunders
Associate, New York
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Outpace Bio Announces $144 Million Oversubscribed Series B

August 1, 2024

Cooley advised Outpace Bio, a cell therapy company using unrivaled artificial intelligence-powered protein design to program immune cells for improved function inside patients battling solid tumors, on its $144 million oversubscribed Series B financing.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Christopher Kimball
Partner, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dillon Martinson
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Lucy Bauer
Associate, Seattle
Karen Gustavson
Associate, Seattle
Millie Heuer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

New York

Rankings and accolades

Chambers USA: International Trade: Export Controls & Economic Sanctions – Nationwide (2022 – 2024)

She's got it all, in-depth knowledge, high level of service and great commercial understanding beyond the four walls of the legal world.

Chambers USA 2023